Literature DB >> 23930196

Emerging and Re-emerging Infectious Diseases: Public Health Perspective.

Saurabh R Shrivastava1, Prateek S Shrivastava, Jegadeesh Ramasamy.   

Abstract

Entities:  

Year:  2013        PMID: 23930196      PMCID: PMC3733046     

Source DB:  PubMed          Journal:  Int J Prev Med        ISSN: 2008-7802


× No keyword cloud information.

DEAR EDITOR,

There have been threats of new diseases emerging due to the evolution/adaptation of microbes and the re-emergence of old diseases due to the development of antimicrobial resistance.[1] Many factors have contributed to the emergence of infectious disease such as unplanned and under-planned urbanization; increased exposure of humans to disease vectors/reservoirs; rapid population growth; inadequate public health infrastructure and irrational antibiotics usage.[23] The impact of the emerging and re-emerging diseases has been enormous at socio-economic and public health levels and it presents a great challenge for the future.[3] Their control requires continuing surveillance, research and training, better diagnostic facilities and remodeled, and well-equipped public health system. There has been an extensive progress in the prevention, control and even elimination of some infectious diseases with improved hygiene and sanitation practices along with the development of antimicrobials and vaccines.[1] However, they still remain a major public health concern, especially in the developing world, in view of the associated high morbidity and mortality. Moreover, there have been threats of new diseases emerging due to the evolution/adaptation of microbes and the re-emergence of old diseases due to the development of antimicrobial resistance.[1] Emerging or re-emerging infectious diseases are those diseases whose incidence has increased in a defined time period and location. If the disease was unknown in a location before, the disease is considered to be emerging. However, if the disease had been present at the location in the past and was considered eradicated or controlled, the disease is considered to be re-emerging.[4] Identification of an emerging disease can occur because of disease showing its presence in population for the first time;[4] or being detected for the first time; or the link between an infectious agent and a chronic disease or a syndrome has recently been established.[2] Multiple hypothesis such as human activity; seasonal variability in human immune system function; seasonal variations in vitamin D levels; seasonality of melatonin; and pathogen infectivity have been proposed that can influence the seasonal patterns of infectious diseases.[5] One of the goals of infectious disease management is the development and production of countermeasures for reducing the magnitude of the problem. Although emergence and re-emergence of infectious disease is a significant public health priority, countermeasures in response to emerging pathogens were inadequate and variable among state health departments.[6] As the epidemiological determinants for most of the infectious diseases are well-known, comprehensive plans and policies for intervention strategies can be developed, encompassing surveillance and response (early detection, prompt investigation and monitoring emerging pathogens, the diseases they cause and the factors influencing their emergence); prevention and control measures (enhancing communication of public health information about emerging diseases and ensuring prompt implementation of prevention strategies); infrastructure (strengthening of public health infrastructure to support surveillance and implementing prevention and control programs); applied research (integrating laboratory science and epidemiology to optimize public health practice and promotion of communication of research findings for the masses);[789] development of newer vaccines against emerging diseases; efficient implementation of international health regulations; frame-work for promoting international cooperation and involvement of all stakeholders; and rational use of antimicrobials to prevent emergence of drug resistance.[210] The impact of the emerging and re-emerging diseases has been enormous at socioeconomic and public health levels and it presents a great challenge for the future. Their control requires continuing surveillance, research and training, better diagnostic facilities and remodeled & well-equipped public health system.
  10 in total

1.  Infections and antimicrobial resistance in long term care facilities: a national prevalence study.

Authors:  M L Moro; E Ricchizzi; F Morsillo; M Marchi; V Puro; C M Zotti; R Prato; G Privitera; A Poli; I Mura; U Fedeli
Journal:  Ann Ig       Date:  2013 Mar-Apr

Review 2.  Factors in the emergence of infectious diseases.

Authors:  S S Morse
Journal:  Emerg Infect Dis       Date:  1995 Jan-Mar       Impact factor: 6.883

3.  Assessment of public health perspectives on responding to an emerging pathogen: carbapenem-resistant Enterobacteriaceae.

Authors:  Alice Y Guh; L Clifford McDonald; Ronda Sinkowitz-Cochran
Journal:  J Public Health Manag Pract       Date:  2013 Jul-Aug

Review 4.  Drivers, dynamics, and control of emerging vector-borne zoonotic diseases.

Authors:  A Marm Kilpatrick; Sarah E Randolph
Journal:  Lancet       Date:  2012-12-01       Impact factor: 79.321

Review 5.  Strongyloidiasis: an emerging infectious disease in China.

Authors:  Chunmei Wang; Jiabao Xu; Xiaohong Zhou; Juan Li; Guiyun Yan; Anthony A James; Xiaoguang Chen
Journal:  Am J Trop Med Hyg       Date:  2013-03       Impact factor: 2.345

6.  Factors influencing the seasonal patterns of infectious diseases.

Authors:  Auda Fares
Journal:  Int J Prev Med       Date:  2013-02

7.  Do we transfer health research results to people?

Authors:  Mahnaz Ashoorkhani; Jaleh Gholami; Reza Majdzadeh
Journal:  Int J Prev Med       Date:  2011-04

8.  On the Use of Fractional Polynomial Models to Assess Preventive Aspect of Variables: An Example in Prevention of Mortality Following HIV Infection.

Authors:  Mohammad Reza Baneshi; Fatemeh Nakhaee; Matthew Law
Journal:  Int J Prev Med       Date:  2013-04

9.  Infectious endocardial intracardiac defibrillator lead, infectious pericarditis, and delayed constrictive pericarditis.

Authors:  Mohsen Mir Mohammad Sadeghi; Akbar Sadri; Ahmad Mirdamadi; Mohammad Reza Samiee Nasab; Elham Majidi; Pouya Mir Mohammad Sadeghi
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

10.  Global trends in emerging infectious diseases.

Authors:  Kate E Jones; Nikkita G Patel; Marc A Levy; Adam Storeygard; Deborah Balk; John L Gittleman; Peter Daszak
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

  10 in total
  2 in total

1.  Expediting knowledge acquisition by a web framework for Knowledge Graph Exploration and Visualization (KGEV): case studies on COVID-19 and Human Phenotype Ontology.

Authors:  Jacqueline Peng; David Xu; Ryan Lee; Siwei Xu; Yunyun Zhou; Kai Wang
Journal:  BMC Med Inform Decis Mak       Date:  2022-06-02       Impact factor: 3.298

2.  COVID-19: An Appeal for an Intersectoral Approach to Tackle With the Emergency.

Authors:  Alessandra Scagliarini; Alberto Alberti
Journal:  Front Public Health       Date:  2020-06-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.